This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Aetiology and pathogenesis

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

CJD is caused by the intracellular deposition of an abnormal form of the normal cellular prion protein. This abnormal form of prion protein, designated PrPsc, is insoluble and proteinase resistant and can be identified with immunocytochemistry on pathological specimens. PrPsc differs from the normal soluble human prion protein, PrPc, not by its sequence of amino acids but by the conformation in which the protein is formed. The PrP gene has been identified, but as yet its normal function is unknown. PrP-knockout transgenic mice develop normally.

The precipitation of PrPsc spreads within the central nervous system because of the ability of PrPsc to catalyse the conversion of endogenous PrPc to PrPsc.

The protein-only, or prion, theory of can explain the three observed natural histories of the spongiform encephalopathies:

  • sporadic:
    • conversion of PrPc to PrPsc may occur as a random event

  • familial:
    • specific PrP mutations make random conversions from PrPc to PrPsc more likely

  • acquired:
    • iatrogenic or environmental exposure to PrPsc may trigger endogenous production of PrPsc

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.